資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/34383
|
| 標題: | Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer |
| 作者: | Lai, Yi-Wen
Hsu, Wen-Jing
Lee, Wen-Ying
Chen, Cheng-Hsun
Tsai, Ying-Huei
Dai, Jia-Zih
Yang, Ching-Chieh
Lin, Cheng-Wei |
| 貢獻者: | Taipei Med Univ, Coll Med, Sch Med, Dept Biochem & Mol Cell Biol
Taipei Med Univ, Coll Med, Grad Inst Med Sci
Chi Mei Med Ctr, Dept Cytopathol
Chi Mei Med Ctr, Dept Radiat Oncol
Chia Nan Univ Pharm & Sci, Dept Pharm
Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr
Kaohsiung Med Univ, Drug Dev & Value Creat Res Ctr |
| 關鍵字: | EMT
glycolysis
YBX1
triple-negative breast cancer |
| 日期: | 2021 |
| 上傳時間: | 2023-11-11 11:48:34 (UTC+8) |
| 出版者: | MDPI |
| 摘要: | Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer as it shows a high capacity for metastasis and poor prognoses. Metabolic reprogramming is one of the hallmarks of cancer, and aberrant glycolysis was reported to be upregulated in TNBC. Thus, identifying metabolic biomarkers for diagnoses and investigating cross-talk between glycolysis and invasiveness could potentially enable the development of therapeutics for patients with TNBC. In order to determine novel and reliable metabolic biomarkers for predicting clinical outcomes of TNBC, we analyzed transcriptome levels of glycolysis-related genes in various subtypes of breast cancer from public databases and identified a distinct glycolysis gene signature, which included ENO1, SLC2A6, LDHA, PFKP, PGAM1, and GPI, that was elevated and associated with poorer prognoses of TNBC patients. Notably, we found a transcription factor named Y-box-binding protein 1 (YBX1) to be strongly associated with this glycolysis gene signature, and it was overexpressed in TNBC. A mechanistic study further validated that YBX1 was upregulated in TNBC cell lines, and knockdown of YBX1 suppressed expression of those glycolytic genes. Moreover, YBX1 expression was positively associated with epithelial-to-mesenchymal transition (EMT) genes in breast cancer patients, and suppression of YBX1 downregulated expressions of EMT-related genes and tumor migration and invasion in MDA-MB-231 and BT549 TNBC cells. Our data revealed an YBX1-glycolysis-EMT network as an attractive diagnostic marker and metabolic target in TNBC patients. |
| 關聯: | CELLS-BASEL, v.10, n.8 |
| 顯示於類別: | [藥學系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| cells10081890.pdf | | 37236Kb | Adobe PDF | 45 | 檢視/開啟 | | index.html | | 0Kb | HTML | 90 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
